TrialReader


Nutritional Support for Rehabilitation In Parkinsonism

NCT03124277 — Not applicable, Completed, 150 participants, Emanuele Cereda

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

A Whey Protein-based Nutritional Supplement Enriched in Vitamin D, Leucine and Calcium for Patients With Parkinsonism Undergoing Rehabilitation Treatment: a Randomized Trial

RegistryNCT03124277
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: single, treatment
Enrollment150 (Actual)
SponsorEmanuele Cereda (Other); collaborators: ASST Gaetano Pini-CTO, U.S. Riabilitazione Parkinson, Fondazione Gaetano e Piera Borghi di Brebbia, Ospedale Generale Di Zona Moriggia-Pelascini
ConditionsDisability Physical
InterventionsFortifit®, Control Group (Dietary supplement, other)
Datesstart 2017-04-26, primary completion 2018-01-17, completion 2018-01-17, first posted 2017-04-21, last updated 2025-05-01
Locations1 site in Italy

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Disability Physical All trials of Fortifit® All trials of Control Group

-Summary

This randomized, trial will tested the hypothesis that nutritional supplementation with whey protein, essential amino acids - mainly leucine - vitamin D and calcium would increase the efficacy of physical rehabilitation in old adults suffering from Parkinson's disease o parkinsonism

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Fortifit®ExperimentalDietary Supplement: Fortifit®Best local diet + two servings (40 grams each) of powder (Fortifit®; Nutricia) which has to be dissolved in 125 ml of water. Per serving, 20 g whey protein, 3 g total leucine, 9 g carbohydrates, 3 g fat, 800 IU vitamin D, and a mixture of vitamins, minerals, and fibers.
Control groupOtherOther: Control GroupBest local diet
  • Fortifit® (Dietary supplement): Best local diet + two servings (40 grams each) of powder (Fortifit®; Nutricia) which has to be dissolved in 125 ml of water. Per serving, 20 g whey protein, 3 g total leucine, 9 g carbohydrates, 3 g fat, 800 IU vitamin D, and a mixture of vitamins, minerals, and fibers.
  • Control Group (Other): Best local diet

+Outcome measures

Primary outcomes

  • Functional status - distance walked during the six minutes walking test [30 days]: Change in the distance walked during the six minutes walking test

Secondary outcomes

  • Functional status - timed up and go test [30 days]: Change in timed up and go test
  • Functional status - Berg balance scale [30 days]: Change in Berg balance scale score
  • Functional status - handgrip strength [30 days]: Change in handgrip strength
  • Functional status - gait speed [30 days]: Change in gait speed (4 minutes walking test)
  • Self-perceived functional status [30 days]: Change in Self-assessment Parkinson's Disease Disability Scale
  • Body weight [30 days]: Change in body weight
  • Muscle mass [30 days]: Change in muscle mass
  • Adverse events [30 days]: Occurrence of adverse events
  • Treatment continuation [30 days]: Likelihood that patients would continue taking the trial treatment as assessed by a self-rating scale

+Eligibility

Sex: All

Inclusion Criteria:

* Parkinson's disease o parkinsonism
* admission for physical rehabilitation
* Informed consent

Exclusion Criteria:

* Any malignant disease during the last five years
* Known kidney failure (previous glomerular filtration rate <30 ml/min);
* Known liver failure (Child B or C)
* Psychiatric disease
* Endocrine disorders associated with disorders of calcium metabolism (excluding osteoporosis)
* Indications related to the study product:

More than 10 μg (400 IU) of daily Vitamin D intake from medical sources More than 500 mg of daily calcium intake from medical sources. Adherence to a high energy or high protein diet up or use of protein containing or amino acid containing nutritional supplements up to three months before starting the study.

* Known allergy to milk, milk products or other components of the proposed interventions
* Indication to or ongoing artificial nutrition support
* Inclusion in other nutrition intervention trials
* Investigator's uncertainty about the willingness or ability of the subject to comply with the protocol requirements
* Refusal

+Locations (1)

FacilityCityCountryStatus
Centro Parkinson, ASST Gaetano Pini-CTOMilanItaly

+Publications

  • Results publication: Barichella M, Cereda E, Pinelli G, Iorio L, Caroli D, Masiero I, Ferri V, Cassani E, Bolliri C, Caronni S, Maggio M, Ortelli P, Ferrazzoli D, Maras A, Riboldazzi G, Frazzitta G, Pezzoli G. Muscle-targeted nutritional support for rehabilitation in patients with parkinsonian syndrome. Neurology. 2019 Jul 30;93(5):e485-e496. doi: 10.1212/WNL.0000000000007858. Epub 2019 Jul 5. PMID 31278117

+Investigators

My Notes